Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs)

Nucleic Acids Research

Volumn 32, Issue 13, 2004, Pages 3792-3798

  Nulf, Christopher J ^a   Corey, David ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPID; NUCLEIC ACID; NUCLEIC ACID BASE; OLIGOMER; PEPTIDE NUCLEIC ACID; LOCKED NUCLEIC ACID; VIRUS RNA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS C VIRUS; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA BINDING; RNA SEQUENCE; RNA TRANSLATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; 5' UNTRANSLATED REGION; ANIMAL; CELL LINE; CHEMISTRY; CONFORMATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN SYNTHESIS; REGULATORY RNA SEQUENCE; RIBOSOME;

HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; PROTEIN BIOSYNTHESIS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RIBOSOMES; RNA, VIRAL; TRANSFECTION;

EID: 3142762898     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh706     Document Type: Article

References (52)

1. Armstrong,G.L., Alter,M.J., McQuillan,G.M. and Margolis,H.S. (2000) The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology, 31, 777-782.
2. Ikeda,K., Saitoh,S., Arase,Y., Chayama,K., Suzuki,Y., Kobayashi,M., Tsubota,A., Nakamura,I., Murashima,N., Kumada,H. and Kawanishi,M. (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology, 29, 1124-1130.
3. Thompson,S.R. and Sarnow,P. (2000) Regulation of host cell translation by viruses and effects on cell function. Curr. Opin. Microbiol., 3, 366-370.
4. Wang,C., Sarnow,P. and Siddiqui,A. (1993) Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol., 67, 3338-3344.
5. Honda,M., Ping,L.H., Rihnbrand,R.C., Amphlett,E., Clarke,B., Rowlands,D. and Lemon,S.M. (1996) Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology, 222, 31-42.
6. Sarnow,P. (2003) Viral internal ribosome entry site elements: novel ribosome-RNA complexes and roles in viral pathogenesis. J. Virol., 77, 2801-2806.
7. Vagner,S., Galy,B. and Pyronnet,S. (2001) Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep., 2, 893-898.
8. Spahn,C.M., Kieft,J.S., Grassucci,R.A., Penczek,P.A., Zhou,K., Doudna,J.A. and Frank,J. (2001) Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit. Science, 291. 1959-1962.
9. Buratti,E., Tsminetzky,S., Zotti,M. and Baralle,F.E. (1998) Functional analysis of the interaction between HCV 5′ UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res., 26, 3179-3187.
10. Lukavsky,P.J., Otto,G.A., Lancaster,A.M., Sarnow,P. and Puglisi,J.D. (2000) Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. Nature Struct. Biol., 7, 1105-1110.
11. McCaffrey,A.P., Ohashi,K., Meuse,L., Shen,S., Lancaster,A.M., Lukavsky,P.J., Sarnow,P. and Kay,M.A. (2002) Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Mol. Ther., 5, 676-684.
12. Blight,K.J., Kolyhalov,A.A., Reed,K.E., Agapov,E.V. and Rice,C.M. (1998) Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. Antivir. Ther., 3 (Suppl. 3), 71-81.
13. Gallego,J. and Varani,G. (2002) The hepatitis C virus internal ribosome-entry site: a new target for antiviral research. Biochem. Soc. Trans., 30, 140-145.
14. Klinck,R., Westhof,E., Walker,S., Afshar,M., Collier,A. and Aboul-Ela,F. (2000) A potential RNA drug target in the hepatitis C virus internal ribosomal entry site. RNA, 6, 1423-1431.
15. Martinand-Mari,C., Lebleu,B. and Robbins,I. (2003) Oligonucleotide-based strategies to inhibit human hepatitis C virus. Oligonucleotides, 13, 539-548.
16. Hanecak,R., Brown-Driver,V., Fox,M.C., Azad,R.F., Furusako,S., Nozaki,C., Ford,C., Sasmor,H. and Anderson,K.P. (1996) Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol., 70, 5203-5212.
17. Brown-Driver,V., Eto,T., Lesnik,E., Anderson,K.P. and Hanecak,R.C. (1999) Inhibition of translation of hepatitis C virus RNA by 2′-modified antisense oligonucleotides. Antisense Nucl. Acid Drug Dev., 9, 145-154.
18. Michel,T., Martinand-Mari,C., Debart,F., Lebleu,B., Robbins,I. and Vasseur,J.-J. (2003) Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation. Nucleic Acids Res., 31, 5282-5290.
19. Tallet-Lopez,B., Aldaz-Carroll,L., Chabas,S., Dausse,E., Staedel,C. and Toulme,J.-J. (2003) Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res., 31, 734-742.
20. Choi,K., Kim,J.H., Li,X., Paek,L.Y., Ha,S.H., Ryu,S.H., Wimmer,E. and Jang,S.K. (2004) Nucleic Acids Res., 32, 1308-1317.
21. Nielsen,P.G., Egholm,M., Berg,R.H. and Buchardt,O. (1991) Sequence-selective recognition of DNA by strand displacement with a thymine substituted polyamide. Science, 254, 1497-1500.
22. Koshkin,A.A. and Wengel,J. (1998) Synthesis of novel 2′,3′-linked bicyclic thymine ribonucleosides. J. Org. Chem., 63, 2778-2781.
23. Obika,S., Nanbu,D., Hari,Y., Andoh,J., Morio,K., Doi,T. and Imanishi,T. (1998) Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett., 39, 5401-5404.
24. Demidov,V.V., Potaman,V.N., Frank-Kamenetskii,M.D., Egholm,M., Buchardt,O., Sonnichsen,S.H. and Nielsen,P.E. (1994) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol., 48, 1310-1313.
25. Egholm,M., Buchardt,O., Christensen,L.R., Behrens,C., Freier,S.M., Driver,D.A., Berg,R.H., Kim,S.K., Norden,B. and Nielsen,P.E. (1993) PNA hybridizes to complementary oligonucleotides obeying Watson-Crick hydrogen bonding rules. Nature, 365, 566-568.
26. Doyle,D.F., Braasch,D.A., Simmons,C.G., Janowski,B.A. and Corey,D.R. (2001) Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry, 40, 53-64.
27. Liu,Y., Braasch,D.A., Nulf,C.J. and Corey,D.R. (2004) Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids. Biochemistry, 43, 1921-1927.
28. Braasch,D.A. and Corey,D.R. (2001) Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol., 8, 1-7.
29. Braasch,D.B., Liu,Y. and Corey,D.R. (2002) Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res., 30, 5160-5167.
30. Grunweller,A., Wyszko,E., Bieber,B., Jahnel,R., Erdmann,V.A. and Kurreck,J. (2003) Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res., 31, 3185-3193.
31. Frieden,M., Christensen,S.M., Mikkelsen,N.D., Rosenbohm,C., Thrue,C.A., Westergaard,M., Hansen,H.F., Orum,H. and Koch,T. (2003) Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res., 31, 6365-6372.
32. Arzumanov,A., Walsh,A.P., Rajwanshi,V.K., Kumar,R., Wengel,J. and Gait,M.J. (2001) Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides. Biochemistry, 40, 14645-14654.
33. Mayfield,L.D. and Corey,D.R. (1999) Automated synthesis of peptide nucleic acids and peptide nucleic acid-peptide conjugates. Anal. Biochem., 268, 401-404.
34. Honda,M., Kaneko,S., Matsushita,E., Kobayashi,K., Abell,G.A. and Lemon,S.M. (2000) Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology, 118, 152-162.
35. Knudsen,H. and Nielsen,P.E. (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res., 24, 494-500.
36. Kurreck,J., WyszKo,E, Gillen,C. and Erdmann,V.A. (2002). Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res., 30, 1911-1918.
37. Honda,M., Ping,L.H., Rijnbrand,R.C., Amphlett,E., Clarke,B., Rowlands,D. and Lemon,S.M. (1996) Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology, 222, 31-42.
38. Honda,M., Rijnbrand,B., Abell,G., Kim,D. and Lemon,S.M. (1999) Natural variation in translational activities of the 5′ nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site. J. Virol., 73, 4941-4951.
39. Buratti,E., Tisminetzky,S., Zotti,M. and Baralle,F.E. (1998) Functional analysis of the interaction between HCV 5′UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res., 26, 3179-3187.
40. Collier,A.J., Gallego,J., Klinck,R., Cole,P.T., Harris,S.J., Harrison,G.P., Aboul-Ela,F., Varani,G. and Walker,S. (2002) A conserved RNA structure within the HCV IRES eIF3-binding site. Nature Struct. Biol., 9, 375-380.
41. Kieft,J.S., Zhou,K., Jubin,R., Murray,M.G., Lau,J.Y. and Doudna,J.A. (1999) The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J. Mol. Biol., 292, 513-529.
42. Kolupaeva,V.G., Pestova,T.V. and Hellen,C.U. (2000) An enzymatic footprinting analysis of the interaction of 40S ribosomal subunits with the internal ribosomal entry site of hepatitis C virus. J. Virol., 74, 6242-6250.
43. Wang,C., Le,S.Y., Ali,N. and Siddiqui,A. (1995) An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA, 1, 526-537.
44. Zhang,H., Hanecak,R., Brown-Driver,V., Azad,R., Conklin,B., Fox,M.C. and Anderson,K.P. (1999) Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant. Antimicrob. Agents Chemother., 43, 347-353.
45. Kim,Y.K., Lee,S.H., Kim,C.S., Seol,S.K. and Jang,S.K. (2003) Long-range RNA-RNA interaction between the 5′ nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation. RNA, 9, 599-606.
46. Hamilton,S.E., Simmons,C.G., Kathriya,I. and Corey,D.R. (1999) Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol., 6, 343-351.
47. Elayadi,A.N., Braasch,D.A. and Corey,D.R. (2002) Implications of high affinity hybridization by locked nucleic acids for inhibition of human telomerase. Biochemistry, 41, 9973-9981.
48. Hertoghs,K.M., Ellis,J.H. and Catchpole,I.R. (2003) Use of locked nucleic acid oligonucleotides to add functionality. Nucleic Acids Res., 31, 5817-5830.
49. Kaihatsu,K., Shah,R.H., Zhao,X. and Corey,D.R. (2003) Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates. Biochemistry, 42, 13996-14003.
50. Bentin,T. and Nielsen,P.E. (1996) Enhanced peptide nucleic acid binding to supercoiled DNA: possible implications for DNA "breathing" dynamics. Biochemistry, 35, 8863-8869.
51. Zhang,X., Simmons,C.G. and Corey,D.R. (2001) Synthesis and intracellular delivery of lactose-labeled PNAs. Bioorg. Med. Chem. Lett., 11, 1269-1272.
52. Hamzavi,R., Dolle,F., Tavitian,B., Dahl,O. and Nielsen,P.E. (2003) Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconj. Chem., 14, 941-954.